PAVmed Price to Book Ratio 2015-2024 | PAVM
Historical price to book ratio values for PAVmed (PAVM) over the last 10 years. The current price to book ratio for PAVmed as of February 20, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| PAVmed Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-02-20 | 0.78 | 0.00 | |
| 2024-09-30 | 1.23 | $-0.88 | -1.40 |
| 2024-06-30 | 0.82 | $-1.95 | -0.42 |
| 2024-03-31 | 2.14 | $-2.32 | -0.92 |
| 2023-12-31 | 4.12 | $-2.80 | -1.47 |
| 2023-09-30 | 4.42 | $-1.98 | -2.23 |
| 2023-06-30 | 6.12 | $-0.11 | -53.38 |
| 2023-03-31 | 5.60 | $1.61 | 3.48 |
| 2022-12-31 | 7.20 | $1.74 | 4.15 |
| 2022-09-30 | 12.90 | $4.64 | 2.78 |
| 2022-06-30 | 14.02 | $7.13 | 1.97 |
| 2022-03-31 | 19.80 | $11.17 | 1.77 |
| 2021-12-31 | 36.90 | $13.79 | 2.68 |
| 2021-09-30 | 128.10 | $6.26 | 20.47 |
| 2021-03-31 | 66.60 | $8.85 | 7.53 |
| 2020-12-31 | 31.80 | $-0.11 | -286.23 |
| 2020-09-30 | 26.70 | $-4.46 | -5.99 |
| 2020-06-30 | 31.65 | $-4.01 | -7.90 |
| 2020-03-31 | 29.70 | $-5.51 | -5.39 |
| 2019-12-31 | 18.00 | $-1.72 | -10.48 |
| 2021-06-30 | 96.00 | $7.63 | 12.58 |
| 2019-09-30 | 14.38 | $-0.99 | -14.57 |
| 2019-06-30 | 17.10 | $-0.83 | -20.71 |
| 2019-03-31 | 16.50 | $-3.13 | -5.28 |
| 2018-12-31 | 14.43 | $-1.37 | -10.55 |
| 2018-09-30 | 19.50 | $2.01 | 9.69 |
| 2018-06-30 | 14.25 | $3.69 | 3.86 |
| 2018-03-31 | 24.60 | $0.21 | 115.93 |
| 2017-12-31 | 34.28 | $-2.93 | -11.68 |
| 2017-09-30 | 81.45 | $-6.64 | -12.26 |
| 2017-06-30 | 67.57 | $-5.68 | -11.90 |
| 2017-03-31 | 75.00 | $-4.85 | -15.46 |
| 2016-12-31 | 103.50 | $-0.36 | -288.46 |
| 2016-09-30 | 210.00 | $1.29 | 163.01 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.009B | $0.002B |
| PAVmed Inc. is a medical device company. Its diversified pipeline of products address unmet clinical needs, which consists of CarpX (TM) to treat carpal tunnel syndrome; NextFlo(TM) and NextCath(TM) a disposable infusion pump; PortIO(TM) and NextCath interventional radiology and Caldus (TM) tissue ablation and cardiovascular intervention. PAVmed Inc. is headquartered in New York City. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $216.728B | 99.43 |
| Thermo Fisher Scientific (TMO) | United States | $203.054B | 24.28 |
| Alcon (ALC) | Switzerland | $44.175B | 29.56 |
| Edwards Lifesciences (EW) | United States | $44.040B | 28.50 |
| IDEXX Laboratories (IDXX) | United States | $36.929B | 42.27 |
| DexCom (DXCM) | United States | $35.044B | 54.35 |
| IQVIA Holdings (IQV) | United States | $34.605B | 19.17 |
| Mettler-Toledo (MTD) | United States | $27.253B | 31.66 |
| Waters (WAT) | United States | $22.442B | 31.84 |
| STERIS (STE) | Ireland | $21.752B | 24.88 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.619B | 0.00 |
| Hologic (HOLX) | United States | $14.406B | 15.55 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.626B | 13.99 |
| Penumbra (PEN) | United States | $11.700B | 105.84 |
| Sysmex ADR (SSMXY) | Japan | $11.461B | 35.94 |
| Globus Medical (GMED) | United States | $11.450B | 29.00 |
| Masimo (MASI) | United States | $9.607B | 46.48 |
| Glaukos (GKOS) | United States | $8.854B | 0.00 |
| Teleflex (TFX) | United States | $8.119B | 12.95 |
| Integer Holdings (ITGR) | United States | $4.804B | 27.23 |
| Inari Medical (NARI) | United States | $4.682B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $3.507B | 0.00 |
| Veracyte (VCYT) | United States | $3.264B | 97.93 |
| Nihon Kohden (NHNKY) | Japan | $2.704B | 14.78 |
| TransMedics (TMDX) | United States | $2.665B | 84.49 |
| LivaNova (LIVN) | United Kingdom | $2.580B | 14.89 |
| Elekta AB (EKTAY) | Sweden | $2.326B | 20.91 |
| Tandem Diabetes Care (TNDM) | United States | $2.083B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.749B | 9.14 |
| Alphatec Holdings (ATEC) | United States | $1.540B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.247B | 0.00 |
| RxSight (RXST) | United States | $1.239B | 0.00 |
| Artivion (AORT) | United States | $1.231B | 81.56 |
| OPKO Health (OPK) | United States | $1.167B | 0.00 |
| Paragon 28 (FNA) | United States | $1.090B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.935B | 0.00 |
| AxoGen (AXGN) | United States | $0.822B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.816B | 17.84 |
| SiBone (SIBN) | United States | $0.760B | 0.00 |
| IRadimed (IRMD) | United States | $0.719B | 37.83 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.717B | 12.19 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.707B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.626B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.590B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.503B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.494B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.485B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.484B | 10.64 |
| AngioDynamics (ANGO) | United States | $0.440B | 0.00 |
| NeuroPace (NPCE) | United States | $0.401B | 0.00 |
| CVRx (CVRX) | United States | $0.378B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.365B | 19.61 |
| Anteris Technologies Global (AVR) | Australia | $0.294B | 0.00 |
| Inogen (INGN) | United States | $0.254B | 0.00 |
| Accuray (ARAY) | United States | $0.231B | 0.00 |
| Nevro (NVRO) | United States | $0.214B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.209B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.183B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.160B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.141B | 0.00 |
| Neuronetics (STIM) | United States | $0.135B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.129B | 0.00 |
| LENSAR (LNSR) | United States | $0.121B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.110B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.103B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.094B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.094B | 14.27 |
| 908 Devices (MASS) | United States | $0.093B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.093B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.085B | 0.00 |
| Hyperfine (HYPR) | United States | $0.083B | 0.00 |
| InspireMD (NSPR) | Israel | $0.081B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.063B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.061B | 31.61 |
| Positron (POSC) | United States | $0.059B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.050B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.041B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.036B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.030B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Tenon Medical (TNON) | United States | $0.005B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |